Loading...
Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis
BACKGROUND: Patients with extensively drug resistant tuberculosis (TB) have limited treatment options with historically poor outcomes. We investigated treatment with 3 oral drugs, bedaquiline (B), pretomanid (Pa) and linezolid (L), (B-Pa-L), with TB bactericidal activity and little pre-existing resi...
Na minha lista:
| Udgivet i: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Massachusetts Medical Society
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6955640/ https://ncbi.nlm.nih.gov/pubmed/32130813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1901814 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|